Author:
Jackson M. J.,Swart T.,Pearce R. K. B.,Jenner P.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference22 articles.
1. Algeri S, Cerletti C, Curcio M, Morselli PL, Bonollo L, Buniva G, Minazzi M, Minoli G (1976) Effect of anticholinergic drugs on gastro-intestinal absorption of l-DOPA in rats and in man. Eur J Pharmacol 35:293–299
2. Close SP, Elliott PJ, Hayes AG, Marriott AS (1990) Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson’s disease. Psychopharmacology 102:295–300
3. Clough CG, Bergmann KJ, Yahr MD (1984) Cholinergic and dopaminergic mechanisms in Parkinson’s disease after long-term l-DOPA administration. Adv Neurol 40:131–140
4. Contin M, Riva R, Martinelli P, Procaccianti G, Albani F, Baruzzi A (1991) Combined l-DOPA-anticholinergic therapy in the treatment of Parkinson’s disease. Effect on l-DOPA bioavailability. Clin Neuropharmacol 14:148–155
5. De Simoni MG, Gonon F, Buda M, Pujol JF (1983) Cholinergic control of catechol metabolism in the rat locus coeruleus as studied by in vivo voltammetry. Eur J Pharmacol 95:65–70
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献